Abstract
This study aims to determine the clinical features and seasonal patterns associated with shigellosis, the antimicrobial resistance frequencies of the isolates obtained during the period 2006–2012 for 22 antibiotics, and the molecular characterization of multidrug-resistant strains isolated from endemic cases of shigellosis in the remote islands of India, with special reference to fluoroquinolone and third-generation cephalosporins resistance. During the period from January 2006 to December 2011, stool samples were obtained and processed to isolate Shigella spp. The isolates were evaluated with respect to their antibiotic resistance pattern and various multidrug resistance determinants, including resistance genes, quinolone resistance determinants, and extended-spectrum β-lactamase (ESBL) production. Morbidity for shigellosis was found to be 9.3 % among children in these islands. Cases of shigellosis occurred mainly during the rainy seasons and were found to be higher in the age group 2–5 years. A wide spectrum of resistance was observed among the Shigella strains, and more than 50 % of the isolates were multidrug-resistant. The development of multidrug-resistant strains was found to be associated with various drug-resistant genes, multiple mutations in the quinolone resistance-determining region (QRDR), and the presence of plasmid-mediated quinolone-resistant determinants and efflux pump mediators. This report represents the first presentation of the results of long-term surveillance and molecular characterization concerning antimicrobial resistances in clinical Shigella strains in these islands. Information gathered as part of the investigations will be instrumental in identifying emerging antimicrobial resistance, for developing treatment guidelines appropriate for that community, and to provide baseline data with which to compare outbreak strains in the future.
Similar content being viewed by others
References
Ahmed AM, Furuta K, Shimomura K, Kasama Y, Shimamoto T (2006) Genetic characterization of multidrug resistance in Shigella spp. from Japan. J Med Microbiol 55:1685–1691
Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651–666
World Health Organization (WHO) (2005) Shigellosis: disease burden, epidemiology and case management. Wkly Epidemiol Rec 80:94–99
Christopher PR, David KV, John SM, Sankarapandian V (2009) Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev (4):CD006784
Ashkenazi S, Levy I, Kazaronovski V, Samra Z (2003) Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 51:427–429
Bennish ML, Salam MA (1992) Rethinking options for the treatment of shigellosis. J Antimicrob Chemother 30:243–247
Zafar A, Hasan R, Nizami SQ, von Seidlein L, Soofi S, Ahsan T, Chandio S, Habib A, Bhutto N, Siddiqui FJ, Rizvi A, Clemens JD, Bhutta ZA (2009) Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan. Int J Infect Dis 13:668–672
Ghosh AR, Sehgal SC (1996) Existing status of shigellosis in Andaman & Nicobar Islands. Indian J Med Res 103:134–137
Roy S, Thanasekaran K, Dutta Roy AR, Sehgal SC (2006) Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of Shigella isolated from Andaman Islands, India. Trop Med Int Health 11:1694–1698
Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sayi DS, Thanasekaran K, Manimunda SP, Ghosh AR, Bharadwaj AP, Singhania M, Roy S (2012) Antimicrobial resistance in Shigella—rapid increase & widening of spectrum in Andaman Islands, India. Indian J Med Res 135:365–370
World Health Organization (WHO) (1987) Manual for laboratory investigation of acute enteric infections. CDD/83.3. WHO, Geneva, Switzerland
Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. M100–S22. CLSI, Wayne, PA
Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sudharama SD, Manimunda SP, Bharadwaj AP, Singhania M, Roy S (2011) Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India. Microb Drug Resist 17:329–332
Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, Yamasaki S, Ramamurthy T (2008) Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol 57:856–863
Talukder KA, Mondol AS, Islam MA, Islam Z, Dutta DK, Khajanchi BK, Azmi IJ, Hossain MA, Rahman M, Cheasty T, Cravioto A, Nair GB, Sack DA (2007) A novel serovar of Shigella dysenteriae from patients with diarrhoea in Bangladesh. J Med Microbiol 56:654–658
Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida K, Yoshida S (2005) Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother 49:1660–1661
Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53:639–645
Fullá N, Prado V, Durán C, Lagos R, Levine MM (2005) Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg 72:851–854
von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh do G, Chaicumpa W, Agtini MD, Hossain A, Bhutta ZA, Mason C, Sethabutr O, Talukder K, Nair GB, Deen JL, Kotloff K, Clemens J (2006) A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 3(9):e353
Zhang W, Luo Y, Li J, Lin L, Ma Y, Hu C, Jin S, Ran L, Cui S (2011) Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother 66:2527–2535
World Health Organization (WHO) (2005) Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. WHO, Geneva, Switzerland. Available online at: http://whqlibdoc.who.int/publications/2005/9241592330.pdf. Accessed 22nd Sep 2012
Niyogi SK (2007) Increasing antimicrobial resistance—an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 13:1141–1143
Maraki S, Georgiladakis A, Christidou A, Scoulica E, Tselentis Y (1998) Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991–1995. APMIS 106:879–883
Egah DZ, Banwat EB, Audu ES, Allanana JA, Danung ML, Damen JG, Badung BP (2003) Multiple drug resistant strains of Shigella isolated in Jos, central Nigeria. Niger Postgrad Med J 10:154–156
Lee JC, Oh JY, Kim KS, Jeong YW, Cho JW, Park JC, Seol SY, Cho DT (2001) Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 109:228–234
Ashkenazi S, May-Zahav M, Sulkes J, Zilberberg R, Samra Z (1995) Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 39:819–823
Fortineau N, Naas T, Gaillot O, Nordmann P (2001) SHV-type extended-spectrum β-lactamase in a Shigella flexneri clinical isolate. J Antimicrob Chemother 47:685–688
Fasano A, Noriega FR, Liao FM, Wang W, Levine MM (1997) Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 40:505–511
Niyogi SK, Vargas M, Vila J (2004) Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clin Microbiol Infect 10:574–576
Briñas L, Zarazaga M, Sáenz Y, Ruiz-Larrea F, Torres C (2002) Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 46(10):3156–3163
Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC (2005) Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol 43:2608–2612
Martínez-Salazar JM, Alvarez G, Gómez-Eichelmann MC (1986) Frequency of four classes of tetracycline resistance determinants in Salmonella and Shigella spp. clinical isolates. Antimicrob Agents Chemother 30:630–631
Peirano G, Agersø Y, Aarestrup FM, dos Prazeres Rodrigues D (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55:301–305
Chopra I, Roberts M (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232–260
Alekshun MN, Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6):1037–1050
Sáenz Y, Briñas L, Domínguez E, Ruiz J, Zarazaga M, Vila J, Torres C (2004) Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 48(10):3996–4001
Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC (2010) Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int J Antimicrob Agents 35:76–79
Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S (2009) Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol 47:1379–1385
Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51:1109–1117
Talukder KA, Khajanchi BK, Islam MA, Dutta DK, Islam Z, Safa A, Khan GY, Alam K, Hossain MA, Malla S, Niyogi SK, Rahman M, Watanabe H, Nair GB, Sack DA (2004) Genetic relatedness of ciprofloxacin resistant Shigella dysenteriae type 1 strains isolated in south Asia. J Antimicrob Chemother 54:730–734
Gad GFM, Abd El-Ghafar F, El-Domany RAA, Hashem ZS (2010) Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases. Braz J Microbiol 41:333–344
Falsafi T, Ehsani A, Niknam V (2009) The role of active efflux in antibiotic-resistance of clinical isolates of Helicobacter pylori. Indian J Med Microbiol 27(4):335–340
Acknowledgments
The authors are thankful to the Indian Council of Medical Research for providing financial grants for the study; to the Director of the institute, Dr. P. Vijayachari, for the administrative support; to the Directorate of Health Services (Andaman & Nicobar Islands) and INHS Dhanwantari for their extensive support and help during the work; and to the other support staff, Mr. S.R. Ghosal, Mr. S. Minj, and Mr. Nathaniel Martin.
Ethics approval
The study was cleared by the institutional ethical committee.
Funding
The study was supported by grants from the Indian Council of Medical Research (vide letter no. Tribal-26/2006/ECD-II). The project was terminated in August 2010.
Transparency declaration
None to declare.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhattacharya, D., Bhattacharya, H., Thamizhmani, R. et al. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis 33, 157–170 (2014). https://doi.org/10.1007/s10096-013-1937-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-013-1937-2